Consolidated Statements Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Retirement of Series A	Retirement of Series B	Impact of adoption of Topic 606	Common Stock	Common Stock Retirement of Series A	Common Stock Retirement of Series B	Additional Paid-In Capital	Additional Paid-In Capital Retirement of Series A	Additional Paid-In Capital Retirement of Series B	Accumulated Deficit	Accumulated Deficit Impact of adoption of Topic 606	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019					71,900
Beginning balance at Dec. 31, 2019	$ 51,698			$ 519	$ 7			$ 135,299			$ (83,395)	$ 519	$ (213)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					332
Stock Option exercises, net	72							72
Stock-based compensation expense	1,010							1,010
Sale of redeemable convertible preferred stock, net of issuance costs (in shares)					38,412
Sale of redeemable convertible preferred stock, net of issuance costs	154,420				$ 4			154,416
Retirement of redeemable convertible preferred stock, including deemed dividend (in shares)						(1,543)	(404)
Retirement of redeemable convertible preferred stock, including deemed dividend:		$ (1,164)	$ (500)						$ (1,164)	$ (500)
Deemed dividend	(6,102)							(1,815)			(4,287)
Comprehensive loss	(67,271)										(67,159)		(112)
Ending balance (in shares) at Dec. 31, 2020					108,697
Ending balance at Dec. 31, 2020	132,682				$ 11			287,318			(154,322)		(325)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Merger and PIPE Shares, net of transaction costs (in shares)					68,069
Merger and PIPE Shares, net of transaction costs	233,340				$ 7			233,333
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger (in shares)					325
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger	4,576							4,576
Issuance of common stock upon exercise of stock options (in shares)					998
Stock Option exercises, net	713							713
Stock-based compensation expense	7,183							7,183
Other	(22)							(22)
Comprehensive loss	$ (127,025)										(126,247)		(778)
Ending balance (in shares) at Dec. 31, 2021	178,089				178,089
Ending balance at Dec. 31, 2021	$ 251,447				$ 18			533,101			(280,569)		(1,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Merger and PIPE Shares, net of transaction costs (in shares)					26,220
Merger and PIPE Shares, net of transaction costs	$ 54,507				$ 3			54,504
Issuance of common stock upon exercise of stock options (in shares)	2,333
Stock-based compensation expense	$ 19,520							19,520
Stock Option exercises, net (in shares)					2,265
Stock Option exercises, net	2,325							2,325
Restricted Stock Units, net (in shares)					94
Other	0
Comprehensive loss	$ (133,897)										(127,905)		(5,992)
Ending balance (in shares) at Dec. 31, 2022	206,668				206,668
Ending balance at Dec. 31, 2022	$ 193,902				$ 21			$ 609,450			$ (408,474)		$ (7,095)